Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation by Hodgson-Zingman Denice M, Karst Margaret L, Zingman Leonid V, Heublein Denise M, Darbar Dawood, Herron Kathleen J, Ballew Jeffrey D, de Andrade Mariza, Burnett John C, Olson Timothy M in The New England journal of medicine (2008).

[PMID: 18614783] PubMed


Atrial fibrillation is a common arrhythmia that is hereditary in a small subgroup of patients. In a family with 11 clinically affected members, we mapped an atrial fibrillation locus to chromosome 1p36-p35 and identified a heterozygous frameshift mutation in the gene encoding atrial natriuretic peptide. Circulating chimeric atrial natriuretic peptide (ANP) was detected in high concentration in subjects with the mutation, and shortened atrial action potentials were seen in an isolated heart model, creating a possible substrate for atrial fibrillation. This report implicates perturbation of the atrial natriuretic peptide-cyclic guanosine monophosphate (cGMP) pathway in cardiac electrical instability.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.